NEW YORK (Reuters) -Asset management firm T. Rowe Price plans to close to new investors its Emerging Europe Fund starting from May 9, it said in a regulatory filing this week, after marking the fund’s Russian securities down to zero last month. The $30 million fund, which invests at least 80% of its assets in…
By David French (Reuters) – The three main Wall Street benchmarks had their best days in over a month on Tuesday, with the Nasdaq closing up 2.2%, as investors responded to positive earnings and dovish comments from two U.S. Federal Reserve officials on interest rate rises. Johnson & Johnson advanced 3.1% to a second record…
By Dawn Chmielewski (Reuters) -Global streaming giant Netflix Inc on Tuesday reported losing subscribers for the first time in more than a decade and predicted more contraction in the second quarter, a rare miss for a company that has been a reliable growth engine for investors. Netflix lost 200,000 subscribers in its first quarter, falling…
By Gertrude Chavez-Dreyfuss NEW YORK (Reuters) – The dollar surged on Tuesday to a 20-year high against the Japanese yen, underpinned by the divergence in monetary policy between a Federal Reserve determined to keep a lid on soaring inflation and a Bank of Japan that has kept interest rates ultra-low. The greenback hit 128.97 yen,…
DALLAS (AP) — A ruling by a federal judge has ended — at least for now — the requirement that people wear masks on planes and public transportation, and there is plenty of confusion about the new, post-mask world of travel. The Justice Department left the door open Tuesday to a possible appeal of the…
By Mimosa Spencer PARIS (Reuters) -Cosmetics group L’Oreal beat expections for first-quarter sales growth on Tuesday, batting away concerns about lockdowns in China and inflation as consumers snapped up high-end beauty products in its key markets. “We are not even close to experiencing a luxury down-turn, we see many people that are affluent and even…
By Dietrich Knauth (Reuters) -Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson, McKesson Corp and Endo International Plc, resolving claims that the companies fueled an opioid addiction crisis, the state attorney general said. Under the settlement, drug distributor McKesson will pay $141 million to the state, while drugmakers Johnson & Johnson…
(Reuters) – Alabama on Tuesday reached $276 million in settlements with Johnson & Johnson, McKesson Corp and Endo Pharmaceutical, resolving the state’s claims that the companies fueled an opioid addiction crisis, the state Attorney General said. (Reporting by Dietrich Knauth)
WASHINGTON (Reuters) – Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that it divest an injectable steroid, the U.S. Federal Trade Commission said on Tuesday. Hikma, which makes anesthetics, pain medications, sedatives, neuromuscular agents and other drugs, announced the deal in September as a way for it…
Key Earnings You Must Watch Earnings season is upon us. Markets have been battered with cautious macro headlines over the past couple of months. Bears warn markets about rising rates, geopolitical turmoil, inflationary pressures, supply chain constraints, and weaker margins. These warnings have won the day as evident by the latest AAII data which saw…
